Galectin Therapeutics
GALT
#8462
Rank
A$0.40 B
Marketcap
A$4.06
Share price
-4.27%
Change (1 day)
-50.94%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2026 (TTM): A-$0.70

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.71. In 2025 the company made an earnings per share (EPS) of A-$0.73 an increase over its 2024 EPS that were of A-$1.15.

EPS history for Galectin Therapeutics from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.70-3.86%
2025A-$0.73-36.84%
2024A-$1.152.7%
2023A-$1.1213.85%
2022A-$0.9825%
2021A-$0.7926.83%
2020A-$0.625.13%
2019A-$0.592.63%
2018A-$0.57-22.45%
2017A-$0.74-35.53%
2016A-$1.15-13.64%
2015A-$1.3312.82%
2014A-$1.18-40%
2013A-$1.9680.56%
2012A-$1.09-32.08%
2011A-$1.6013.98%
2010A-$1.41-22.5%
2009A-$1.81185.71%
2008A-$0.63-70.83%
2007A-$2.18118.18%
2006A-$1.00-54.17%
2005A-$2.18-14.29%
2004A-$2.5447.37%
2003A-$1.72-13.64%
2002A-$1.99-24.14%
2001A-$2.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
A-$18.46 2,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A-$0.20-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA